Effect of Herbal Medicine on Vaginal Epithelial Cells: A Systematic Review and Meta-analysis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: The present meta-analysis aimed to assess the effect of the herbal medicine on the vaginal epithelial cells (VECs) among the menopausal subjects. Methods: The literature related to VECs exposed to various herbal medicines in menopausal women were searched on three databases, MEDLINE (1966-August 2017), Scopus (1990-August 2017) and Cochrane Library (Cochrane Central Register of Controlled Trials; 2014). Results: Totally, the meta-analysis was conducted on 11 randomised controlled trials. Based on the findings, the standardized mean difference (SMD) of maturation value (MV) was observed to be elevated by 0.48% (95% interval confidence [CI], 0.108-0.871; P = 0.012), as well as the heterogeneity was high (I2 = 84%; P < 0.001). The MV revealed a significant increase in soy group (SMD, 0.358; 95% CI, 0.073-0.871; P = 0.014) compared to the control group. Conclusions: The herbal medicines exhibited a statistically significant effect on the VECs. A significant effect on the VECs was also found in the subgroup analysis of the patients, who received soy. However, further and extensive studies are required to achieve reliable outcomes. (J Menopausal Med 2018;24:11-16)
Abstract
Objectives: The present meta-analysis aimed to assess the effect of the herbal medicine on the vaginal epithelial cells (VECs) among the menopausal subjects. Methods: The literature related to VECs exposed to various herbal medicines in menopausal women were searched on three databases, MEDLINE (1966-August 2017), Scopus (1990-August 2017) and Cochrane Library (Cochrane Central Register of Controlled Trials; 2014). Results: Totally, the meta-analysis was conducted on 11 randomised controlled trials. Based on the findings, the standardized mean difference (SMD) of maturation value (MV) was observed to be elevated by 0.48% (95% interval confidence [CI], 0.108-0.871; P = 0.012), as well as the heterogeneity was high (I2 = 84%; P < 0.001). The MV revealed a significant increase in soy group (SMD, 0.358; 95% CI, 0.073-0.871; P = 0.014) compared to the control group. Conclusions: The herbal medicines exhibited a statistically significant effect on the VECs. A significant effect on the VECs was also found in the subgroup analysis of the patients, who received soy. However, further and extensive studies are required to achieve reliable outcomes. (J Menopausal Med 2018;24:11-16)
참고문헌 (25)
- Fatemeh Abdi, "Hops for Menopausal Vasomotor Symptoms: Mechanisms of Action", 대한폐경학회지, 22(2), pp.62~64 (2016), 대한폐경학회
- Ghazanfarpour M, "The relationship between women's attitude towards menopause and menopausal symptoms among postmenopausal women", Gynecol Endocrinol, 31, pp.860~865 (2015)[DOI]
- Parastoo Golshiri, "Age at Natural Menopause and Related Factors in Isfahan, Iran", 대한폐경학회지, 22(2), pp.87~93 (2016), 대한폐경학회
- 이해혁, "Expression of Ezrin in Vagina Cells of Postmenopausal Rats after Dietary Administration of Omega-3 Fatty Acid Formula", 대한폐경학회지, 20(3), pp.97~103 (2014), 대한폐경학회
- Ashraf Direkvand-Moghadam, "Quality of Life among Iranian Infertile Women in Postmenopausal Period: A Cross-sectional Study", 대한폐경학회지, 22(2), pp.108~113 (2016), 대한폐경학회
- Levis S, "Design and baseline characteristics of the soy phytoestrogens as replacement estrogen (SPARE) study--a clinical trial of the effects of soy isoflavones in menopausal women", Contemp Clin Trials, 31, pp.293~302 (2010)[DOI]
- 김현경, "The Recent Review of the Genitourinary Syndrome of Menopause", 대한폐경학회지, 21(2), pp.65~71 (2015), 대한폐경학회
- Kaari C, "Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study", Maturitas, 53, pp.49~58 (2006)[DOI]
- Scarabin PY, "Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk", Lancet, 362, pp.428~432 (2003)[DOI]
- Ghazanfarpour M, "The application of soy isoflavones for subjective symptoms and objective signs of vaginal atrophy in menopause: A systematic review of randomised controlled trials", J Obstet Gynaecol, 36, pp.160~171 (2016)[DOI]
- Moseley AM, "Evidence for physiotherapy practice: a survey of the Physiotherapy Evidence Database (PEDro)", Aust J Physiother, 48, pp.43~49 (2002)[DOI]
- Borenstein M, "Comprehensive meta-analysis" (2005), Biostat
- Baird DD, "Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women", J Clin Endocrinol Metab, 80, pp.1685~1690 (1995)
- Murkies AL, "Dietary flour supplementation decreases postmenopausal hot flushes: effect of soy and wheat", Maturitas, 21, pp.189~195 (1995)[DOI]
- Carmignani LO, "The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomized controlled trial", Maturitas, 67, pp.262~269 (2010)[DOI]
- Chiechi LM, "The effect of a soy rich diet on the vaginal epithelium in postmenopause: a randomized double blind trial", Maturitas, 45, pp.241~246 (2003)[DOI]
- Radhakrishnan G, "Evaluation of isoflavone rich soy protein supplementation for postmenopausal therapy", Pak J Nutr, 8, pp.1009~1017 (2009)[DOI]
- Knight DC, "Effects on menopausal symptoms and acceptability of isoflavonecontaining soy powder dietary supplementation", Climacteric, 4, pp.13~18 (2001)[DOI]
- Levis S, "Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: a randomized, double-blind trial", Arch Intern Med, 171, pp.1363~1369 (2011)[DOI]
- Márcia Constantino Colli, "Evaluation of the Efficacy of Flaxseed Meal and Flaxseed Extract in Reducing Menopausal Symptoms", Journal of Medicinal Food, 15(9), pp.840~845 (2012), 한국식품영양과학회[DOI]
- Knight DC, "The effect of Promensil, an isoflavone extract, on menopausal symptoms", Climacteric, 2, pp.79~84 (1999)[DOI]
- Manonai J, "Effect of Pueraria mirifica on vaginal health", Menopause, 14, pp.919~924 (2007)[DOI]
- D'Anna R, "Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study", Menopause, 14, pp.648~655 (2007)[DOI]
- Ghazanfarpour M, "Topical administration of isoflavones for treatment of vaginal symptoms in postmenopausal women: A systematic review of randomised controlled trials", J Obstet Gynaecol, 35, pp.783~787 (2015)[DOI]
- Saghafi N, "Effects of phytoestrogens in alleviating the menopausal symptoms: A systematic review and meta-analysis", Iran J Pharm Res, 16, pp.99~111 (2017)[DOI]